Dhoke, N.R.; Kim, H.; Azzag, K.; Crist, S.B.; Kiley, J.; Perlingeiro, R.C.R.
A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs. Cells 2024, 13, 972.
https://doi.org/10.3390/cells13110972
AMA Style
Dhoke NR, Kim H, Azzag K, Crist SB, Kiley J, Perlingeiro RCR.
A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs. Cells. 2024; 13(11):972.
https://doi.org/10.3390/cells13110972
Chicago/Turabian Style
Dhoke, Neha R., Hyunkee Kim, Karim Azzag, Sarah B. Crist, James Kiley, and Rita C. R. Perlingeiro.
2024. "A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs" Cells 13, no. 11: 972.
https://doi.org/10.3390/cells13110972
APA Style
Dhoke, N. R., Kim, H., Azzag, K., Crist, S. B., Kiley, J., & Perlingeiro, R. C. R.
(2024). A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs. Cells, 13(11), 972.
https://doi.org/10.3390/cells13110972